日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of the COVID-19 pandemic on paediatric renal tumour presentation and management, a SIOP renal tumour study group study

COVID-19 大流行对儿童肾肿瘤临床表现和治疗的影响:一项 SIOP 肾肿瘤研究组研究

Roy, Prakriti; van Peer, Sophie E; Dandis, Rana; Duncan, Catriona; de Aguirre-Neto, Joaquim Caetano; Verschuur, Arnauld; de Camargo, Beatriz; Karim-Kos, Henrike E; Boschetti, Luna; Spreafico, Filippo; Ramirez-Villar, Gema L; Graf, Norbert; van Tinteren, Harm; Pritchard-Jones, Kathy; van den Heuvel-Eibrink, Marry M

Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas: Standard of Care and Treatment Recommendations from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)

儿童非横纹肌肉瘤软组织肉瘤:欧洲儿童软组织肉瘤研究组 (EpSSG) 的标准护理和治疗建议

Ferrari, Andrea; Brennan, Bernadette; Casanova, Michela; Corradini, Nadege; Berlanga, Pablo; Schoot, Reineke A; Ramirez-Villar, Gema L; Safwat, Akmal; Guillen Burrieza, Gabriela; Dall'Igna, Patrizia; Alaggio, Rita; Lyngsie Hjalgrim, Lisa; Gatz, Susanne Andrea; Orbach, Daniel; van Noesel, Max M

Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients

多药耐药转运蛋白谱揭示 MDR3 是胚基威尔姆斯肿瘤患者分层的标志

Lourdes Hontecillas-Prieto, Daniel J Garcia-Dominguez, Diego Pascual Vaca, Rosa Garcia-Mejias, David Marcilla, Gema L Ramirez-Villar, Carmen Saez, Enrique de Álava

Correction: Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients

更正:多药耐药转运蛋白谱分析显示 MDR3 可作为肾母细胞瘤患者分层的标志物

Hontecillas-Prieto, Lourdes; Garcia-Dominguez, Daniel J; Vaca, Diego Pascual; Garcia-Mejias, Rosa; Marcilla, David; Ramirez-Villar, Gema L; Saez, Carmen; de Álava, Enrique